Advanced search
Publication Cover
Scandinavian Journal of Clinical and Laboratory Investigation Volume 42, 1982 - Issue 4
Submit an article Journal homepage
2
Views
33
CrossRef citations to date
0
Altmetric
Original Article

Immunoradiometric quantification of tissue plasminogen activator secreted by fetal organs. Comparison with urokinase

Lars Holmberg Departments of Paediatrics and Coagulation Laboratory, Malmö allmänna sjukhus, Malmö, Sweden; Department of Gynaecology and Obstetrics, Lasarettet, University of Lund, Sweden; Department of Physiological Chemistry, University of Umeå, Sweden
,
Ann-Charlotte Kristoffersson Departments of Paediatrics and Coagulation Laboratory, Malmö allmänna sjukhus, Malmö, Sweden; Department of Gynaecology and Obstetrics, Lasarettet, University of Lund, Sweden; Department of Physiological Chemistry, University of Umeå, Sweden
,
Ingegerd Lecander Departments of Paediatrics and Coagulation Laboratory, Malmö allmänna sjukhus, Malmö, Sweden; Department of Gynaecology and Obstetrics, Lasarettet, University of Lund, Sweden; Department of Physiological Chemistry, University of Umeå, Sweden
,
Per Wallén Departments of Paediatrics and Coagulation Laboratory, Malmö allmänna sjukhus, Malmö, Sweden; Department of Gynaecology and Obstetrics, Lasarettet, University of Lund, Sweden; Department of Physiological Chemistry, University of Umeå, Sweden
&
Birger Åstedt Departments of Paediatrics and Coagulation Laboratory, Malmö allmänna sjukhus, Malmö, Sweden; Department of Gynaecology and Obstetrics, Lasarettet, University of Lund, Sweden; Department of Physiological Chemistry, University of Umeå, Sweden
Pages 347-354 | Received 19 Nov 1981, Accepted 26 Feb 1982, Published online: 17 Mar 2010

Citations (33)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

G. Bjorlin, H. Ljungner, J. Wennerberg & B. Atedt. (1987) Plasminogen Activators in Human Xenografted Oro-pharyngeal Squamous Cell Carcinomas. Acta Oto-Laryngologica 104:5-6, pages 568-572.
Read now
H. Pschera, A. Kjaeldgaard & B. Larsson. (1986) Fibrinolytic Activity in Amniotic Fluid During Late Pregnancy. Acta Obstetricia et Gynecologica Scandinavica 65:5, pages 417-420.
Read now
Göran Larsson & Birger åstedt. (1986) Plasminogen Activator and Fibrinogen/Fibrin Degradation Products At Conization of the Uterine Cervix. Acta Obstetricia et Gynecologica Scandinavica 65:4, pages 331-333.
Read now
Birger Åstedt. (1985) Does Estrogen Replacement Therapy Predispose to Thrombosis?. Acta Obstetricia et Gynecologica Scandinavica 64:sup130, pages 71-74.
Read now
G. Urdén & M. Blombäck. (1984) Determination of tissue plasminogen activator in plasma samples by means of a radioimmunoassay. Scandinavian Journal of Clinical and Laboratory Investigation 44:6, pages 495-502.
Read now
Birger Åstedt & Fredrik Nordenskjöld. (1984) Plasminogen activators in endometriosis. Acta Obstetricia et Gynecologica Scandinavica 63:sup123, pages 23-24.
Read now

Articles from other publishers (27)

M. C. Alessi & I. Juhan-Vague. 1999. Laboratory Techniques in Thrombosis - a Manual. Laboratory Techniques in Thrombosis - a Manual 231 237 .
S.C.L. Koh, C. Anandakumar, S Arulkumaran, S.E. Chua, W.K. Yuen, B.L. Ng & S.S. Ratnam. (1995) Amniotic fluid plasminogen activators and inhibitors and TAT-complex levels during 2nd trimester pregnancy and labour. Fibrinolysis 9:2, pages 121-126.
Crossref
Marco Cardosi, Wah On Ho, Dale Athey & Calum McNeil. (2005) An electrochemical assay for tissue plasminogen activator (t‐PA). Electroanalysis 4:3, pages 285-290.
Crossref
Stefan Lethagen, Peter Rugarn & David Bergqvist. (1991) Blood loss and safety with desmopressin or placebo during aorto-iliac graft surgery. European Journal of Vascular Surgery 5:2, pages 173-178.
Crossref
A. Kjaeldgaard, H. Pschera, B. Larsson, P. Gaffney & B. Åstedt. (1989) Plasminogen activators and inhibitors in amniotic fluid. Fibrinolysis 3:4, pages 203-206.
Crossref
F M Booyse, J Scheinbuks, P H Lin, M Traylor & R Bruce. (1988) Isolation and interrelationships of the multiple molecular tissue-type and urokinase-type plasminogen activator forms produced by cultured human umbilical vein endothelial cells.. Journal of Biological Chemistry 263:29, pages 15129-15138.
Crossref
T. Soszka, N.E. Kirschbaum, G.J. Stewart & A.Z. Budzynski. (1988) Effect of fibrinogen-clotting enzymes on secretion of plasminogen activators from cultured human endothelial cells. Fibrinolysis 2:1, pages 49-57.
Crossref
I.R. MacGregor, S. MacDonald, J. Dawes, L.R. Micklem & K. James. (1987) A monoclonal antibody enzyme linked immunosorbent assay (ELISA) directed towards a fibrin binding region of tissue-type plasminogen activator. Fibrinolysis 1:4, pages 247-252.
Crossref
B. Åstedt, I. Lecander & T. Ny. (1987) The placental type plasminogen activator inhibitor, PAI 2. Fibrinolysis 1:4, pages 203-208.
Crossref
L. Tengborn. (1987) The effect of stanozolol on various types of defective fibrinolysis. Fibrinolysis 1:1, pages 29-32.
Crossref
Marianne Kjaeldgaard & A. Kjaeldgaard. (1987) Immunological characterization of plasminogen activators in human parotid saliva. Archives of Oral Biology 32:12, pages 855-857.
Crossref
Gunnar Plate, Eibert Einarsson, Bo Eklöf & Lilian Tengborn. (2016) Is Abnormal Coagulation or Defective Fibrinolysis of Aetiological Importance in the Development of Deep Venous Thrombosis?. Phlebology: The Journal of Venous Disease 1:3, pages 149-158.
Crossref
Esbjörn Lantz & Maurizio Pandolfi. (1986) Fibrinolysis in cornea and conjunctiva: Evidence of two types of activators. Graefe's Archive for Clinical and Experimental Ophthalmology 224:5, pages 393-396.
Crossref
A. KJAELDGAARD & M. KJAELDGAARD. (2008) Immunological characterization of plasminogen activators in human mixed saliva. Acta Physiologica Scandinavica 126:3, pages 443-447.
Crossref
M.M. McArthur, I.R. MacGregor, C.V. Prowse, N.R. Hunter, J. Dawes & D.S. Pepper. (1986) The use of human endothelial cells cultured in flat wells and on microcarrier beads to assess tissue plasminogen activator and factor VIII related antigen release. Thrombosis Research 41:4, pages 581-587.
Crossref
Michèle Reboud-Ravaux. (1985) Les activateurs du plasminogène: aspects généraux et développements récents. Biochimie 67:12, pages 1197-1216.
Crossref
M. Stalder, J. Hauert, E. K. O. Kruithof & F. Bachmann. (2008) Release of vascular plasminogen activator (v‐PA) after venous stasis: electrophoretic—zymographic analysis of free and complexed v‐PA. British Journal of Haematology 61:1, pages 169-176.
Crossref
L.A. Erickson, R.R. Schleef, T. Ny & D.J. Loskutoff. (1985) The Fibrinolytic System of the Vascular Wall. Clinics in Haematology 14:2, pages 513-530.
Crossref
A Larsson & B Astedt. (1985) Immunohistochemical localisation of tissue plasminogen activator and urokinase in the vessel wall.. Journal of Clinical Pathology 38:2, pages 140-145.
Crossref
K. Danø, P.A. Andreasen, J. Grøndahl-Hansen, P. Kristensen, L.S. Nielsen & L. Skriver. 1985. 139 266 .
B. CASSLÉN. 1985. 141 144 .
A. Kjaeldgaard, B. Larsson & B. Åstedt. (1984) Regulatory effect of contraceptive steroids on the release of tissue-type plasminogen activator in vitro. Contraception 30:4, pages 355-362.
Crossref
H. Ljungnér, G. Björlin & B. Åstedt. (1984) Immunological identification of plasminogen activators in normal and malignant tissues of the oral cavity in man. International Journal of Oral Surgery 13:4, pages 334-338.
Crossref
Bertil Casslén & Birger Åstedt. (1983) Occurrence of both urokinase and tissue plasminogen activator in the human endometrium. Contraception 28:6, pages 553-564.
Crossref
H Ljungner, L Holmberg, A Kjeldgaard, I M Nilsson & B Astedt. (1983) Immunological characterisation of plasminogen activators in the human vessel wall.. Journal of Clinical Pathology 36:9, pages 1046-1049.
Crossref
I.R. MacGregor & C.V. Prowse. (1983) Tissue plasminogen activator in human plasma measured by radioimmunoassay. Thrombosis Research 31:3, pages 461-474.
Crossref
Bertil Casslén & Birger Åstedt. (1983) Reduced plasminogen activator content of the endometrium in oral contraceptive users. Contraception 28:2, pages 181-188.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.